Scarica l'app Stockscreener
28.67
2.32%
0.65
Dopo l'orario di chiusura:
28.67
Precedente Chiudi:
$28.02
Aprire:
$27.58
Volume 24 ore:
1.19M
Relative Volume:
1.70
Capitalizzazione di mercato:
$2.18B
Reddito:
-
Utile/perdita netta:
$-64.16M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
$-69.06M
1 W Prestazione:
-0.31%
1M Prestazione:
-11.07%
6M Prestazione:
-10.71%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$27.58
$28.94
Intervallo di 1 settimana:
$27.00
$30.00
Portata 52W:
$25.77
$50.23
Cg Oncology Inc Stock (CGON) Company Profile
Nome
Cg Oncology Inc
Settore
Industria
Telefono
(949) 419-6203
Indirizzo
400 SPECTRUM CENTER DRIVE, IRVINE
Confronta CGON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
28.67 | 2.18B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2024-06-28 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Iniziato | Goldman | Neutral |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-14 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cg Oncology Inc Borsa (CGON) Ultime notizie
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 2,503 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
CG Oncology (NASDAQ:CGON) Shares Down 4.3%Time to Sell? - MarketBeat
CG Oncology Enters Oversold Territory (CGON) - Nasdaq
State Street Corp Raises Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World
State Street Corp Acquires 717,722 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock By Investing.com - Investing.com Australia
Franklin Resources Inc. Has $46.16 Million Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Cg oncology director Song Hong Fang sells shares worth $19.6 million - Investing.com India
Hong Fang Song Sells 700,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) Stock - MarketBeat
Cg oncology director Leonard Post sells $28,840 in stock - Investing.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Marketscreener.com
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase - EIN News
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook - Investing.com
CG Oncology's SWOT analysis: cretostimogene's potential reshapes NMIBC stock outlook By Investing.com - Investing.com South Africa
Jane Street Group LLC Buys 138,400 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Latham & Watkins Advises on CG Oncology’s Public Offering - Legal Desire News Network
CG Oncology (NASDAQ:CGON) Sees Large Volume IncreaseWhat's Next? - MarketBeat
Wellington Management Group LLP Acquires 308,852 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology (NASDAQ:CGON) vs. LENZ Therapeutics (NASDAQ:LENZ) Head-To-Head Survey - Defense World
CG Oncology (NASDAQ:CGON) versus Fresh Tracks Therapeutics (NASDAQ:FRTX) Head-To-Head Comparison - Defense World
Cg Oncology Inc (NASDAQ: CGON) Has Great Upside Potential - Stocks Register
CG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of Cretostimogene (NASDAQ:CGON) - Seeking Alpha
Fmr LLC Raises Stock Position in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology Launches Major $204M IPO with Shares Priced at $28, Backed by Top Wall Street Banks - StockTitan
CG Oncology Announces Pricing of Public Offering - Marketscreener.com
CG Oncology Announces Pricing of Public Offering - GlobeNewswire Inc.
CG Oncology announces 7.3M share offering - MSN
Neo Ivy Capital Management Takes Position in CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
Why CG Oncology (CGON) Stock Is Down 9% - Benzinga
CGONCG Oncology, Inc. Latest Stock News & Market Updates - StockTitan
CG Oncology announces offering of 8M shares of common stock - TipRanks
CG Oncology Announces Proposed Public Offering - The Manila Times
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
CG Oncology Launches Major 8M Share Public Offering, Backed by Top Wall Street Banks - StockTitan
CG Oncology files to sell 8M shares of common stock - TipRanks
CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by BNP Paribas Financial Markets - MarketBeat
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer Research Fellowship Award - Marketscreener.com
CG Oncology’s (CGON) “Outperform” Rating Reiterated at Royal Bank of Canada - Defense World
Charles Schwab Investment Management Inc. Purchases 202,262 Shares of CG Oncology, Inc. (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 Shares - MarketBeat
Royal Bank of Canada Reaffirms Outperform Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
HC Wainwright Reaffirms Buy Rating for CG Oncology (NASDAQ:CGON) - MarketBeat
Cg oncology director Leonard Post sells shares worth $34,541 By Investing.com - Investing.com Nigeria
Cg oncology director Leonard Post sells shares worth $34,541 - Investing.com
Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer - Reuters.com
CG Oncology keeps stock target with buy rating, impresses with Phase 3 results - Investing.com
Cg Oncology Inc’s (CGON) -6.54% Drop Is A Reason To Reconsider. - Stocks Register
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - The Manila Times
CG Oncology Launches Groundbreaking Research Fellowship for Bladder Cancer Innovation - StockTitan
Cg Oncology Inc Azioni (CGON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):